Gene signatures in U-BIOPRED severe asthma for molecular phenotyping and precision medicine: time for clinical use (2023)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/17476348.2023.2278606
Publication URI: http://dx.doi.org/10.1080/17476348.2023.2278606
Type: Journal Article/Review
Parent Publication: Expert Review of Respiratory Medicine
Issue: 11